Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
Clinical trial NCT03838185 · COMPLETED
Trial details
- NCT number
- NCT03838185
- Sponsor
- Abrexa Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2020-02-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.